Please login to the form below

Not currently logged in
Email:
Password:

pay-for-delay

This page shows the latest pay-for-delay news and features for those working in and with pharma, biotech and healthcare.

Concordia accused of overcharging NHS for thyroid drug

Concordia accused of overcharging NHS for thyroid drug

Last December, Pfizer and Flynn Pharma were ordered to pay £84m after being accused of charging excessive and unfair prices for anti-epilepsy treatment phenytoin sodium capsules, but have appealed the ... ruling. Meanwhile, earlier in 2016 the CMA fined

Latest news

  • Lundbeck challenge to EC pay-for-delay ruling fails Lundbeck challenge to EC pay-for-delay ruling fails

    Lundbeck challenge to EC pay-for-delay ruling fails. Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... The Celexa case judgment was the first in a broad investigation by the EC of pay-for-delay practices by the pharma

  • Pharma's reputation rises, but pricing still a sore point Pharma's reputation rises, but pricing still a sore point

    All told, 45% of 2015's respondent patient groups rated pharma as 'poor' at this activity, with pricing policies for hepatitis drugs, HIV treatments and rare disease therapies highly cited for ... of transparency (particularly on pricing and side effects)

  • UK government fines GSK over 'pay-for-delay' deals UK government fines GSK over 'pay-for-delay' deals

    UK government fines GSK over 'pay-for-delay' deals. Merck KGaA and Actavis also fined for their involvement. ... The culmination of the investigation is a £37.6m (around $55m) fine for GSK and smaller penalties for other companies involved in the

  • Servier announces job cuts as pressures mount Servier announces job cuts as pressures mount

    Management will mobilise all means available to minimise the social impact of this project and to identify, in consultation with staff representatives, the most appropriate support solutions for the employees concerned," ... The announcement comes after

  • US Senator sets sights on medicine pricing US Senator sets sights on medicine pricing

    Americans pay - by far - the highest prices in the world for prescription drugs," said Sanders, adding that in 2013 the US spent nearly 40% more on prescriptions per person than Canada, ... Other clauses include a ban on pay-for-delay deals for generic

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • Pharma deals in May 2015 Pharma deals in May 2015

    This is not the first such case for Teva, as the FTC also filed suit last September for an alleged pay for delay relating to AndroGel. ... Five Prime/ bluebird bio. Licence agreement. For development of CAR-T cell therapies.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Lars Bruening
Shaping healthcare
Bayer’s Lars Bruening talks about moving to the UK as the market works its way through a series of seismic changes...
No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...

Infographics